Solid Biosciences Inc
SLDBHealthcare|Biotechnology|USA
$10.40
-0.71 (-6.38%)
Tangible Book
$3.80
Earnings Power
$3.33
Clinical Trials (19)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT07160634 A Study of SGT-003 Gene Therapy in Ambulant Males With Duchenne Muscular Dystrophy (IMPACT DUCHENNE) | Duchenne Muscular Dystrophy | P3 | Recruiting | 80 | RCT, Double-blind | SGT-003, Placebo |
| NCT03368742 Microdystrophin Gene Transfer Study in Adolescents and Children With DMD | Duchenne Muscular Dystrophy | P1P2 | Active | 12 | Open-label | — |
| NCT06138639 A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) | Duchenne Muscular Dystrophy | P1P2 | Recruiting | 60 | Open-label | — |
| NCT07180355 A Study of SGT-212 Gene Therapy in Friedreich's Ataxia | Friedreich's Ataxia (FA) | P1 | Recruiting | 10 | Open-label | SGT-212 |
| NCT07148089 A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) | Catecholaminergic Polymorphic Ventricular Tachycardia | P1 | Recruiting | 18 | Open-label | SGT-501 |
| NCT00349492 A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer | Small Cell Lung Cancer | P3 | Completed | 372 | RCT, Open-label | IP |
| NCT00011921 Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer | Lung Cancer | P3 | Unknown | 430 | RCT | filgrastim, carboplatin, epirubicin hydrochloride, etoposide, etoposide phosphate, ifosfamide, paclitaxel |
| NCT00876031 Trial for Localised High-risk Rhabdomyosarcoma and Rhabdomyosarcoma-like Soft Tissue Sarcoma | Soft Tissue Sarcoma | P3 | Completed | 195 | RCT, Open-label | trofosfamide, idarubicin, etoposide |
| NCT00020566 Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | Sarcoma | P3 | Unknown | 1,200 | RCT | dactinomycin, busulfan, doxorubicin hydrochloride, etoposide, ifosfamide, melphalan, vincristine sulfate |
| NCT00004921 High-Dose Chemotherapy Compared With Standard Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer That Has Been Removed During Surgery | Ovarian Cancer | P3 | Completed | — | RCT | filgrastim, carboplatin, cyclophosphamide, melphalan, paclitaxel |
| NCT00005589 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma | Lymphoma | P3 | Completed | 460 | RCT, Open-label | filgrastim, rituximab, carmustine, cyclophosphamide, cytarabine, etoposide, melphalan |
| NCT00025636 Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's Lymphoma | Lymphoma | P3 | Unknown | 220 | RCT | filgrastim, carmustine, cisplatin, cyclophosphamide, cytarabine, dexamethasone, etoposide, melphalan, methotrexate, vincristine sulfate |
| NCT01689194 Efficacy Study of Genexol-PM and Cisplatin in Locally Advanced Head and Neck Cancer | Locally Advanced Head and Neck Squamous Cell Carcinoma | P2 | Completed | 53 | Open-label | genexolPM + cisplatin |
| NCT00805012 Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC) | Head and Neck Squamous Cell Carcinoma | P2 | Terminated | 96 | RCT, Open-label | docetaxel+CDDP, docetaxel+S-1 |
| NCT00830245 A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer | Leptomeningeal Carcinomatosis, Non-small Cell Lung Cancer | P2 | Terminated | 20 | Open-label | Erlotinib |
| NCT00921167 A Study to Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas | Glioblastoma, Astrocytoma | P2 | Completed | 32 | Open-label | Bevacizumab/Irinotecan |
| NCT00623558 Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC) | Head and Neck Neoplasm | P2 | Completed | 92 | RCT, Open-label | Cetuximab, Docetaxel, Cisplatin |
| NCT03680365 Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families | Duchenne Muscular Dystrophy, Burden, Dependency | Completed | 60 | — | — | |
| NCT05657938 Evaluation of Home Based Assessments on Participants With DMD | Duchenne Muscular Dystrophy | Completed | 17 | — | — |